This post was originally published on this site The Alzheimer’s Association and the African Methodist Episcopal Church (AME Church) announced a three-year partnership to promote greater involvement in the fight against Alzheimer’s (AD) and to heighten awareness of the support needed by patients and their families. Through the leadership of its International Health Commission, the AME…
About Alzheimer’s Disease
Walking into a room and forgetting why you went into the room is normal. Walking into a room and forgetting what room you are in is not normal. Alzheimer’s disease is the most common form of dementia and affects one in ten people over the age of 65. Unfortunately, the exact cause of Alzheimer’s disease is not fully understood however leading scientific experts in the field attribute the illness to the irreversible and progressive generalized degeneration of the brain. Alzheimer’s disease goes well beyond the forgetfulness that may accompany aging, and typically first signs include difficulty remembering current information or performing new tasks. Ongoing hallmark symptoms include impaired memory function, difficulty performing everyday tasks, and neurobehavioral abnormalities. Currently, there is no known cure for Alzheimer’s disease, and multi-disciplinary treatment focuses on symptom management and limiting progression.
Conditions
Alzheimer’s News
Caregivers’ Priorities Shift During the Holidays
This post was originally published on this site Some of us are still adjusting to writing 2019 on bank checks, and here we are knocking on the door of the holidays. The older we become, the faster the years seem to zoom by. Just yesterday, we were children dreaming of snow at Christmas and our…
Enrollment Complete for Clinical Trial of LymPro, an Alzheimer’s Investigational Blood Diagnostic Test
This post was originally published on this site The second part of a clinical study evaluating the use of a blood diagnostic test for Alzheimer’s disease — called the Lymphocyte Proliferation Test (LymPro Test) — is now fully enrolled, the trial’s sponsor, Breakthrough Diagnostics, announced. The trial is ongoing at Leipzig University in Germany, and top-line results are expected…
$1.34M Grant Will Be Used to Broaden Psychosocial Research into Dementia Care
This post was originally published on this site The National Institutes of Health (NIH) has awarded the Alzheimer’s Association $1.34 million to find more evidence-based ways to enhance care and support for those with Alzheimer’s disease (AD) or other dementias, and their care partners. The five-year grant will support a project titled “Leveraging an Interdisciplinary Consortium to…
UW Scientist Awarded $17.2M Grant to Study Link Between Eye Health and Alzheimer’s
This post was originally published on this site A team led by a University of Washington (UW) School of Medicine scientist will use a $17.2 million National Institute on Aging (NIA) grant to study whether degenerative eye diseases are linked to Alzheimer’s disease (AD). The award went to Cecilia Lee, an assistant professor of ophthalmology. Along…
Antioxidant Compound, with Aid of Baker’s Yeast, May Offer Oral Supplement to Offset Alzheimer’s
This post was originally published on this site A natural compound with antioxidative properties that might help to delay the onset of neurodegenerative diseases like Alzheimer’s can now be produced in baker’s yeast, a study reports. This new way of producing ergothioneine, as the compound is known, may lead to a commercially viable new treatment…
Veterans with Brain Injuries or PTSD Face a Greater Risk of Alzheimer’s Disease
This post was originally published on this site Veterans Day has come and gone in the U.S. for another year. Proving that we’re a grateful nation, it was punctuated with speeches by dignitaries and pride-filled social media posts dedicated to the fathers, mothers, sisters, and brothers who serve, or have served, in one of the…
Humana and Seniorlink Offering Tech-Enabled Coaching to Dementia Caregivers
This post was originally published on this site Expanding their existing relationship, Seniorlink and Humana are offering a program that provides additional care management and support to families caring for individuals with dementia, including Alzheimer’s disease. The dementia management program, which covers Humana Medicare Advantage members, capitalizes on Seniorlink’s experience and expertise in supporting caregivers. Specifically, it…
Study into Way of Detecting Alzheimer’s via Eye Scans Goal of Optina Diagnostics, Wagner Center Partnership
This post was originally published on this site Laying the foundation for what could be a pivotal clinical trial into Alzheimer’s (AD) detection, Optina Diagnostics and Wagner Macula & Retina Center will collaborate on a “real-world” study aimed at advancing Optina’s retinal deep phenotyping platform. “It brings together a whole new paradigm for the way we think…
Neflamapimod Fails to Improve Memory But Shows Impact on Tau Levels in Phase 2b Study, EIP Pharma Announces
This post was originally published on this site A Phase 2b study of oral neflamapimod in treating mild Alzheimer’s disease met its secondary goals of statistically significant drops in phospho-tau and tau protein levels in the cerebrospinal fluid (CSF) of treated patients compared to those given a placebo, EIP Pharma announced. But the trial failed to show evidence…
Why National Alzheimer’s Awareness Month Matters
This post was originally published on this site In 1983, U.S. President Ronald Reagan designated November as National Alzheimer’s Awareness Month. Coincidentally, 11 years later, Reagan was diagnosed with Alzheimer’s. The 40th U.S. president revealed his fate in a letter to the American people in 1994, writing: “I now begin the journey that will lead…
Vaccine Decreases Tau Tangles, Improves Memory and Motor Function in Mouse Model of Alzheimer’s, Study Says
This post was originally published on this site An experimental vaccine targeting the toxic form of tau protein reduced cellular tangles in the brain — a hallmark of Alzheimer’s — and eased behavioral and motor defects in a mouse model of the disease, a study showed. By generating high levels of anti-tau antibodies, this vaccine…